ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,716,889, issued on Aug. 25, was assigned to The Hong Kong Polytechnic University (Hong Kong) and City Unversity of Hong Kong (Hong Kong).

"Microfluidic-based device for in vivo wound infection model and uses thereof" was invented by Song Lin Chua (Hong Kong), Bee Luan Khoo (Hong Kong) and Yang Liu (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an integrated microfluidic-based device for establishing a wound infection in vivo model suitable for high throughput bioassay such as potential drug screening, in vivo dosing optimization, host-microbe or microbe-microbe interactions under the influence of specific agents...